title: [A case of synchronous double cancer of stomach and lung responding to neoadjuvant chemotherapy].
abstract: A 66-year-old male was admitted to our hospital because of dyspnea in 2007. Cancerous pleural effusion and gastric cancer was diagnosed, and the chemotherapy consisted of S-1 + DOC was started for Stage IV gastric cancer. In 2009, lung cancer was found. The chemotherapy was changed to CDDP + CPT-11. This chemotherapy was effective for both lung and gastric cancers. Operation was performed for both tumors in 2010, and the pathological diagnosis revealed that gastric cancer was pStage I, Cur A, and the lung cancer was pStage IA, R0. Pathologic histology inspection of both tumors was judged to be effective for the chemotherapy prior to resection.
authors.affiliation: Dept. of Surgery, Tokyo Metropolitan Ohtsuka Hospital.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Sakamoto
authors.forename: Haruya
authors.initials: H
authors.lastname: Koshiishi
authors.forename: Masaki
authors.initials: M
authors.lastname: Kakimoto
authors.forename: Kiyotaka
authors.initials: K
authors.lastname: Nishida
authors.forename: Taiki
authors.initials: T
authors.lastname: Masuda
authors.forename: Noriyasu
authors.initials: N
authors.lastname: Chika
authors.forename: Takashi
authors.initials: T
authors.lastname: Hosokawa
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Matsuyama
authors.forename: Hiromi
authors.initials: H
authors.lastname: Tokita
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Goto
authors.forename: Tetsunori
authors.initials: T
authors.lastname: Yoshimura
authors.forename: Takashi
authors.initials: T
authors.lastname: Okamura
authors.forename: Naoaki
authors.initials: N
authors.lastname: Dan
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kato
authors.forename: Yosuke
authors.initials: Y
authors.lastname: Mitsuhashi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002945:Cisplatin / Q000008:administration & dosage; D000077143:Docetaxel; D004338:Drug Combinations; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D020360:Neoadjuvant Therapy; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D010094:Oxonic Acid / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D004338:Drug Combinations; D043823:Taxoids; C079198:S 1 (combination); D005641:Tegafur; D000077143:Docetaxel; D010094:Oxonic Acid; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin